Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Spectral Medical Inc.TSX: EDT.TO

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue growth accelerates

Q1 FY2026 revenue of CA$891K rose 55.8% year over year, ahead of the +26.1% change in trailing-twelve-month revenue. Sequentially, it rose 133.2% from the prior quarter. Over 3 fiscal years it compounded at +13.6% a year.

Context

  • Revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of CA$2.16M (-11.7%) for the fiscal year ending Dec 2026, a slowdown from the +6.8% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$891K+133.2% QoQ
Last fiscal yearDec 2025
CA$2.44M+6.8% YoY
LTMMar 2026
CA$2.76M+26.1% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+55.8%-25.7%-81.5 pp
1 year+6.8%-11.7%-18.5 pp
3-year CAGR+13.6%+168.4%+154.8 pp
5-year CAGR+141.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

CAD · from the income statement

Latest · FY2025
2.44M CAD
Year-over-year change
+6.8%
4-year CAGR
+5.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +26.1% is the 4th highest of 7, against a peer median of +27.3%.
  • Over three fiscal years its annual growth of +13.6% compares with a peer median of +35.1%.
EDT.TO Competitors
Revenue for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$318.43M CAD-7.2%+11.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$310.92M CAD+15.6%-5.1%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$66.52M CAD+25.7%+38.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$51.17M USD+65.5%+207.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$50.92M USD+28.9%+35.4%
PRN.TOProfound Medical Corp.LTM Mar 2026$18.76M USD+64.7%+34.8%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$2.76M CAD+26.1%+13.6%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$0 USD——
Peer median (excluding EDT.TO) —+27.3%+35.1%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.